Nástroje

iconicon Akciový screener
iconicon Kalendář zisků
iconicon Super investoři

Ostatní

iconicon Návod
IČ: 19940963

5. května 521, 501 01 Turnov
Zásady GDPR
Podmínky služby
Všechna práva vyhrazena @ 2024, Fundamenty.cz
Proudly created by draftspot.net
Coherus Oncology, Inc.
Coherus Oncology, Inc.
CHRS
Valuace
70
Růst
15
Zdraví
63
Cena
$ 1.37
Dnes
--0.06 (-3.61%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.2B
Obrat
0B
Zisk
0B
Aktiva
1B
Dluh
0B
ROE
177%
ROA
30%
PE
1
PS
4
Cena 1R
1-2
⌀ Cena
1.17
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
09-03-2026
Poslední dividenda

Profil

Biofarmaceutická společnost Coherus BioSciences, Inc. se zaměřuje na trh s biosimilními a imunonkologickými přípravky především ve Spojených státech. Společnost uvádí na trh UDENYCA, biosimilní přípravek Neulasta, dlouhodobě působící faktor kolonie stimulující granulocyty ve Spojených státech. Mezi jeho produkty patří biosimilary Humira, Avastin a Lucentis. Společnost také vyvíjí Toripalimab, novou protilátku proti PD- 1 pro léčbu melanomu v Číně druhé linie; Bevacizumab biosimilar; a CHS- 1420, anti-TNF přípravek kandidát, jako adalimumab biosimilar; Ranibizumab biosimilar. Společnost Coherus BioSciences, Inc. má licenční smlouvy se společnostmi Selexis SA; AbbVie, Inc.; Pfizer, Inc.; Bioeq AG; Innovent Biologics (Suzhou) Co., Ltd. a Junshi Biosciences. Společnost byla dříve známá jako BioGenerics, Inc. a v dubnu 2012 změnila svůj název na Coherus BioSciences, Inc. Společnost Coherus BioSciences, Inc. byla založena v roce 2010 a sídlí v Redwood City v Kalifornii.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
228
Založení
2014-11-06
Adresa
333 Twin Dolphin Drive
CEO
Dennis M. Lanfear
Web
www.coherus.com

Podobné společnosti

OABI
OmniAb, Inc.
$ 1.45
+ $ 0.07
IVVD
Invivyd, Inc.
$ 1.53
- $ 0.06
CDXS
Codexis, Inc.
$ 1.68
- $ 0.02
PLX
Protalix BioTherapeutics, Inc.
$ 2.17
- $ 0.03
CCCC
C4 Therapeutics, Inc.
$ 2.30
- $ 0.04
SGMO
Sangamo Therapeutics, Inc.
$ 0.49
+ $ 0.02

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 20252024202320222021202020192018201720162015201420132012
Total Revenues42.242.2267.0257.2211.0326.6475.8356.11.61.6190.130.031.12.81.9
Cost of Revenues13.813.8117.6162.870.157.637.717.10.00.00.00.00.00.00.0
Gross Profit28.428.4149.494.5141.0269.0438.2339.01.61.6190.130.031.12.81.9
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues12.711.610.37.654.170.865.02.391.574.6
Cost of Revenues4.03.73.42.733.920.729.61.485.632.7
Gross Profit8.77.96.94.920.350.035.40.95.941.9
Operating Income TTM 20252024202320222021202020192018201720162015201420132012
R&D Expenses0.00.00.0109.4199.4363.1142.894.2110.2162.4254.4213.178.231.334.9
Selling General & Admin Expenses0.00.00.0185.6198.5169.7139.1137.094.271.351.636.017.67.55.5
Depreciation & Amortization3.93.95.33.83.8-0.30.62.63.23.43.01.90.70.40.2
Total Operating Expenses209.5209.5261.1301.5397.8532.8281.8231.2204.4233.7306.0249.195.838.740.4
Operating Income-181.1-181.1-111.7-203.2-256.9-263.9156.3107.8-204.4-232.1-115.9-219.1-64.7-36.0-38.5
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.025.325.6
Selling General & Admin Expenses0.00.00.00.00.00.00.00.048.948.2
Depreciation & Amortization0.91.01.01.01.01.51.21.51.11.6
Total Operating Expenses54.652.252.350.462.556.455.968.774.373.9
Operating Income-45.9-44.3-45.5-45.4-42.2-6.4-20.5-67.8-68.4-32.0
Net Income TTM 20252024202320222021202020192018201720162015201420132012
Interest Income0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Interest Expense9.09.027.240.532.523.021.217.69.79.68.00.03.95.31.5
Other Expense-2.0-2.0140.2-35.1-34.9-23.2-20.6-15.04.73.4-3.9-4.8-18.6-12.37.0
IBT-183.1-183.128.5-238.3-291.8-287.1135.792.8-209.4-238.3-127.8-223.9-87.2-53.6-33.0
Income Tax Expense0.00.00.0-0.434.919.23.52.94.79.40.7-7.4-15.4-7.18.5
Net Income168.0-170.328.5-237.9-326.6-306.3132.289.8-209.3-238.2-127.3-223.3-87.1-53.6-33.0
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income0.00.00.00.00.00.00.00.00.010.3
Interest Expense2.22.32.32.25.35.45.311.110.610.3
Other Expense-0.5-0.20.6-2.0-8.5-4.47.6-0.2-10.7-8.0
IBT-46.3-44.5-44.9-47.4-50.7-10.8-12.9-68.0-79.7-40.0
Income Tax Expense0.00.00.00.00.00.00.00.0-10.6-0.4
Net Income-37.6-35.5297.8-56.6-50.7-10.8-12.9102.9-79.7-39.6
Per Share Data TTM 20252024202320222021202020192018201720162015201420132012
EPS$0.00$0.00$0.00$-2.53$-4.21$-4.06$1.85$1.29$-3.22$-4.48$-3.04$-6.01$-10.64$-2.97$-1.83
EPS Diluted$0.00$0.00$0.00$-2.53$-4.21$-4.06$1.62$1.23$-3.22$-4.48$-3.04$-6.01$-10.64$-2.97$-1.83
Shares Outstanding120.4120.4114.694.277.675.471.469.765.053.141.937.18.218.118.1
Diluted Shares Outstanding120.4120.4114.894.277.675.483.573.265.053.141.937.18.218.118.1
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.71$-0.41
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.71$-0.41
Shares Outstanding120.4116.2116.1115.9115.4115.2114.8112.7111.597.7
Diluted Shares Outstanding120.4116.2116.1115.9115.4115.2114.8125.5111.597.7
Current Assets TTM 2024202320222021202020192018201720162015201420132012
Cash And Equivalents159.2126.0102.963.5417.2541.2177.772.4126.9124.9158.2150.439.614.5
Short Term Investments0.00.014.9128.10.00.00.00.00.00.00.00.00.00.0
Total Cash & ST Investments159.2126.0117.7191.7417.2541.2177.772.4126.9124.9158.2150.439.614.5
Accounts Receivable313.6122.3260.5110.0123.0157.0142.0-1.70.01.91.64.20.40.2
Inventory62.270.162.6115.193.392.255.11.70.0-4.8-4.4-8.20.010.0
Other Current Assets23.023.234.822.924.525.013.50.10.13.02.84.05.70.1
Total Current Assets557.9341.6475.6416.7633.5790.4374.772.4126.9124.9158.2150.445.724.8
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents103.4216.982.4126.097.7159.2259.8102.980.372.9
Short Term Investments88.320.70.00.00.00.00.014.950.871.8
Total Cash & ST Investments191.7237.682.4126.097.7159.2259.8117.7131.1144.7
Accounts Receivable250.5119.662.4122.3198.8313.6284.1260.5216.5141.3
Inventory2.04.53.570.147.662.262.062.666.864.0
Other Current Assets16.718.4161.823.224.923.021.634.830.035.5
Total Current Assets461.0380.2310.2341.6369.0557.9627.5475.6444.4385.5
Long-Term Assets TTM 2024202320222021202020192018201720162015201420132012
Net Property, Plant & Equipment3.32.811.08.87.820.116.56.712.810.810.54.51.71.6
Goodwill0.00.00.90.00.90.90.90.90.90.90.90.90.00.0
Intangible Assets55.553.670.70.02.62.62.62.62.62.62.62.60.00.0
Long-Term Investments0.50.00.00.00.00.00.00.00.00.00.00.00.00.0
Other Long-Term Assets57.750.571.349.534.527.614.116.919.439.240.128.80.00.1
Total Long-Term Assets116.9107.0154.064.245.951.334.227.135.753.554.236.81.81.7
Total Assets674.9448.5629.6480.8679.3841.6408.999.5162.6178.5212.4187.247.426.5
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment1.61.92.32.82.93.34.211.06.16.9
Goodwill0.00.00.00.00.00.00.00.90.90.0
Intangible Assets49.552.353.053.654.355.557.170.745.65.8
Long-Term Investments0.00.00.00.00.00.50.50.50.00.0
Other Long-Term Assets4.45.05.750.578.857.774.30.186.871.4
Total Long-Term Assets55.659.360.9107.0136.0116.9136.1154.0139.484.1
Total Assets516.5439.5371.1448.5505.0674.9763.5629.6583.8469.6
Current Liabilities TTM 2024202320222021202020192018201720162015201420132012
Accounts Payable76.828.535.211.516.215.226.015.315.720.629.510.83.73.9
Short-Term Debt4.11.72.14.33.50.00.00.00.20.924.111.24.21.7
Other Current Liabilities382.1252.8294.438.659.466.389.018.03.633.01.45.831.53.6
Current Liabilities463.0283.0331.854.579.081.5115.033.328.456.4106.051.853.711.3
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable24.937.640.928.521.976.838.335.237.129.3
Short-Term Debt1.81.81.71.71.64.1176.82.14.54.4
Other Current Liabilities347.1225.7212.4252.8272.0382.1323.2294.4198.1135.7
Current Liabilities373.8265.1255.0283.0295.6463.0538.3331.8239.7169.4
Long-Term Liabilities TTM 2024202320222021202020192018201720162015201420132012
Long-Term Debt290.1268.2478.7471.1408.3404.0178.4103.1101.4100.30.00.00.00.0
Capital Leases4.25.05.39.410.79.910.30.00.00.00.00.00.00.0
Def. Tax Liability1.11.11.10.00.00.00.00.00.00.00.00.00.00.0
Total Liabilities759.0580.5823.0618.3581.6560.7303.7138.1132.1159.1219.3120.589.817.3
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt38.939.3268.2268.2268.2294.2304.4478.7474.2474.8
Capital Leases3.74.24.65.05.44.24.75.35.97.1
Def. Tax Liability1.11.11.11.11.11.11.11.10.00.0
Total Liabilities428.7319.6554.5580.5593.0759.0845.4823.0717.4644.4
Total Common Equity TTM 2024202320222021202020192018201720162015201420132012
Common Stock0.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Retained Earnings-1,489.5-1,551.0-1,579.5-1,341.6-1,049.9-762.8-895.0-984.8-775.5-537.3-410.0-186.7-99.6-46.0
Comprehensive Income-0.3-0.3-0.2-0.2-0.3-0.3-0.6-0.3-0.8-0.6-0.4-0.5-0.6-0.2
Total Common Equity-84.1-132.0-193.4-137.497.7281.0105.2-38.630.519.4-6.966.8-42.49.2
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock0.00.00.00.00.00.00.00.00.00.0
Retained Earnings-1,345.3-1,309.8-1,607.6-1,551.0-1,500.3-1,489.5-1,476.6-1,579.5-1,499.8-1,460.2
Comprehensive Income-0.2-0.3-0.3-0.3-0.3-0.3-0.3-0.2-0.3-0.3
Total Common Equity87.8119.8-183.5-132.0-88.0-84.1-81.8-193.4-133.6-174.8
Other TTM 2024202320222021202020192018201720162015201420132012
Total Debt298.3269.9480.8471.1408.3404.0178.4103.1101.4100.30.00.04.21.7
Book Value-84.1-132.0-193.4-137.497.7281.0105.2-38.630.519.4-6.966.8-42.49.2
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value87.8119.8-183.5-132.0-88.0-84.1-81.8-193.4-133.6-174.8
Cash Flow From Operating Activities TTM 20252024202320222021202020192018201720162015201420132012
Net Income-29.3168.028.5-237.9-291.8-287.1132.289.8-209.4-238.3-127.8-223.9-87.2-53.6-33.0
Depreciation & Amortization4.70.05.33.83.73.52.93.33.23.43.01.90.70.40.2
Stock-Based Compensation35.30.027.843.150.751.445.733.634.836.127.416.711.12.00.4
Change Working Capital41.6-5.855.9-36.8-79.342.4-32.5-113.910.3-5.1-159.291.128.441.411.6
Change In Accounts Receivable-34.193.6149.4-150.713.134.1-15.2-142.08.31.9-0.30.9-2.1-0.1-0.2
Change In Accounts Payable46.1-19.6-3.923.8-4.50.9-9.89.9-0.5-4.5-7.619.95.3-0.43.4
Change In Inventories-49.6-17.1-32.0-46.7-47.3-6.3-36.2-48.2-5.5-0.18.3-1.3-16.2-0.40.1
Other Non-cash Items-124.6-300.7-137.952.975.5143.16.015.7-1.73.25.34.69.212.99.5
Cash from Operations-54.30.00.0-174.9-241.1-37.4154.128.4-159.3-200.3-252.5-108.0-23.915.4-18.3
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income241.2-35.5297.8-56.6-50.7-10.8-54.9102.9-79.7-39.6
Depreciation & Amortization2.11.01.01.05.21.51.21.51.10.9
Stock-Based Compensation10.83.45.45.46.46.40.07.310.810.0
Change Working Capital-12.8-9.4-23.710.948.2-11.274.3-11.46.4-27.6
Change In Accounts Receivable106.2-4.355.350.956.37.876.68.6-44.1-75.3
Change In Accounts Payable0.8-15.3-12.213.00.00.039.50.6-0.86.8
Change In Inventories-18.52.53.8-22.2-6.5-6.9-7.1-11.5-11.8-19.2
Other Non-cash Items-261.0-5.8-327.213.519.5-48.139.1-147.1118.01.2
Cash from Operations0.00.00.00.00.00.00.00.0-12.9-54.3
Cash Flow From Investing Activities TTM 20252024202320222021202020192018201720162015201420132012
Capital Expenditure0.00.00.0-0.3-2.0-1.3-7.1-12.9-0.8-4.6-6.5-6.2-2.8-0.4-1.8
Acquisitions228.10.00.00.80.01.30.01.7-0.70.00.00.02.30.00.0
Investments0.2-103.80.0-19.5-127.4-182.5-273.8-20.2-42.9-74.30.00.00.00.00.0
Sales of Investment322.321.514.9157.60.0181.4274.020.443.274.50.00.00.00.00.0
Other Investing Activities-6.30.00.05.9-37.4-137.3-7.5-1.70.00.00.0-0.80.00.00.0
Cash from Investing316.20.00.0144.6-166.9-138.4-14.4-12.7-1.2-4.4-6.5-6.9-0.5-0.4-1.8
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure0.00.00.00.00.00.00.00.00.00.0
Acquisitions0.00.00.00.00.00.00.00.00.10.2
Investments-14.3-68.9-20.70.00.00.00.00.00.20.0
Sales of Investment19.81.70.00.00.00.00.014.936.243.4
Other Investing Activities0.00.00.00.00.00.00.00.0-1.17.0
Cash from Investing0.00.00.00.00.00.00.00.035.250.5
Cash Flow From Financing Activities TTM 20252024202320222021202020192018201720162015201420132012
Debt Repaid-186.80.00.00.0-190.8-0.7-1.30.00.00.00.00.00.00.00.0
Debt Issued5.9269.9-210.99.8253.54.9226.975.31.71.2100.30.0-4.22.51.7
Issuance of Common Stock14.80.00.071.76.440.90.08.2101.7206.8124.3122.885.40.00.0
Repurchase of Common Stock-1.20.00.00.00.00.00.00.00.0-0.50.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Other Financing Activities-3.40.00.0-2.1238.711.6225.281.23.70.5101.9-0.150.510.026.9
Cash from Financing-175.60.00.069.654.351.9223.989.4105.4206.8226.2122.7136.010.026.9
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.00.00.0
Debt Issued40.7-0.3-228.90.00.0-28.5-182.80.32.2-0.6
Issuance of Common Stock0.00.00.00.00.00.00.00.0-0.111.4
Repurchase of Common Stock0.00.00.0-0.30.00.00.00.03.30.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.00.7-0.3
Cash from Financing0.00.00.00.00.00.00.00.00.411.1
Cash position TTM 20252024202320222021202020192018201720162015201420132012
Net Change in Cash85.9-37.122.939.4-353.6-124.0363.7104.7-54.62.0-33.37.8110.825.06.9
Closing Cash Balance159.289.1126.3103.364.0417.6541.6177.973.2126.9124.9158.2150.439.614.5
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash-14.5-113.6134.5-43.628.3-61.7-100.5156.922.27.4
Closing Cash Balance89.1103.6217.282.7126.398.0159.2259.8102.980.7
Free Cash Flow TTM 20252024202320222021202020192018201720162015201420132012
Free Cash Flow-54.3-138.5-20.4-175.2-243.2-38.7147.115.5-160.1-204.9-259.1-114.2-26.815.1-20.0
Real Free Cash Flow-89.6-138.5-48.2-218.3-293.9-90.1101.4-18.1-194.9-240.9-286.5-130.9-37.813.0-20.5
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow-19.7-46.3-46.6-25.828.6-62.059.7-46.8-13.0-54.3
Real Free Cash Flow-30.5-49.7-52.1-31.222.2-68.559.7-54.1-23.8-64.3
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E1.1-12.9-1.4
P/S4.3359.4
P/B2.1-8.55.2
P/FCF-1.1-3.6-1.5
Market cap$0.2$0.3
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets7.9 %49.3 %0 %
Debt to Income24.2 %-1194.2 %0 %
Debt to Free cash flow-24.9 %-129.3 %0 %
Interest expense percentage-5 %6.7 %44.7 %
Current ratio1.2 3.3 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE191.4 %276.6 %0 %
ROA32.5 %-51.7 %0 %
CapEx to Revenue0 %21.8 %0 %
RaD to Revenue0 %766.6 %0 %
ROEM137,817.0 581403

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin47.8 %79 %68.7 %
Operating margin-212.4 %-1029.8 %35.5 %
Net margin185.4 %-1150.8 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding116.2 mil 67.8 mil
Employee count0.3 tis 0.2 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás
Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader